Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2017 (2017), Article ID 8383251, 4 pages
https://doi.org/10.1155/2017/8383251
Case Report

Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism

The Teaching (General) Hospital-Kandy, Kandy, Sri Lanka

Correspondence should be addressed to N. D. B. Ehelepola

Received 26 February 2017; Accepted 28 March 2017; Published 11 April 2017

Academic Editor: Walter Zidek

Copyright © 2017 N. D. B. Ehelepola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. European Thyroid Association, World thyroid day 2016, http://www.eurothyroid.com/files/download/world-thyroid-day-2016.pdf.
  2. American Thyroid Association, General Information/Press Room, http://www.thyroid.org/media-main/about-hypothyroidism/.
  3. R. Farias Moeller, N. Zecavati, R. Sherafat-Kazemzadeh, S. Aleinikoff, and W. Rennert, “Adolescent with Rhabdomyolysis due to Undiagnosed Hypothyroidism,” Case Reports in Pediatrics, vol. 2011, Article ID 670673, 4 pages, 2011. View at Publisher · View at Google Scholar
  4. World Health Organization, “Global Health Observatory (GHO) data,” Raised cholesterol, http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/.
  5. S. Zhou, C. C. Xue, X. Yu, C. Li, and G. Wang, “Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring,” Therapeutic Drug Monitoring, vol. 29, no. 6, pp. 687–710, 2007. View at Publisher · View at Google Scholar
  6. R. Zhang, H. H. Ran, C. Y. Lu et al., “Rhabdomyolysis induced by simvastatin-diltiazem interaction in unrecognized hypothyriodism,” Journal of Geriatric Cardiology, vol. 7, no. 2, article 126, 2010, http://www.jgc301.com/ch/reader/create_pdf.aspx?file_no=20100211&flag=1. View at Google Scholar
  7. P. Trenkwalder, “Antihypertensive treatment with calcium channel blockers: pharmacological pornography or useful intervention?” Nephrology Dialysis Transplantation, vol. 19, no. 1, pp. 17–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Tyteca, V. Desfontaine, G. Desmet, and D. Guillarme, “Possibilities of retention modeling and computer assisted method development in supercritical fluid chromatography,” Journal of Chromatography A, vol. 1381, pp. 219–228, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. J. Lewin, J. M. Nappi, and M. H. Taylor, “Rhabdomyolysis with concurrent atorvastatin and diltiazem,” Annals of Pharmacotherapy, vol. 36, no. 10, pp. 1546–1549, 2002. View at Publisher · View at Google Scholar
  10. UpToDate, “Hashimoto encephalopathy,” http://www.uptodate.com/contents/hashimoto-encephalopathy?source=search_result&search=Hashimoto%27s+thyroiditis&selectedTitle=3%7E109.
  11. R. Mocellin, M. Walterfang, and D. Velakoulis, “Hashimoto's encephalopathy: epidemiology, pathogenesis and management,” CNS Drugs, vol. 21, no. 10, pp. 799–811, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Santra, S. Phaujdar, A. Rudra, and P. S. Dutta, “Hashimoto's encephalopathy,” The Journal of the Association of Physicians of India, vol. 60, pp. 48–51, 2012, http://japi.org/may_2012/13_cr_hashimotos_encephalopathy.pdf. View at Google Scholar